Advertisement

The Latest

Laboratory and diagnostics companies are urging Congress to halt Medicare reimbursement cuts for hundreds of clinical tests set to take effect Jan. 31. CMS plans to implement up to 15% reductions to Medicare payments for about 800 clinical laboratory tests,…

Eli Lilly will build a $6 billion new facility in Huntsville, Ala., to manufacture active pharmaceutical ingredients for small molecule and peptide medicines, including the company’s oral GLP-1 candidate, orforglipron. The site will support domestic production of therapies and strengthen pharmaceutical…

Beaufort (S.C.) Memorial has marked a construction milestone for its new Bluffton Community Hospital, hosting a topping-off ceremony Dec. 4 to celebrate completion of the facility’s structural frame, according to a Dec. 5 news release from the health system. Four…

Cybersecurity threats, climate change and financial pressures are threatening  hospital supply chains, according to the American Society of Health-System Pharmacists’ “2026 Pharmacy Forecast,” released Dec. 9. The report, presented at ASHP’s Midyear Clinical Meeting in Las Vegas, draws on insights…

Multiple states and major medical societies say they will continue to universally recommend hepatitis B vaccination for newborns in a break with newly revised guidance from the CDC’s Advisory Committee on Immunization Practices.  The ACIP committee voted Dec. 5 to…

U.S. hospitals increasingly offer less-comprehensive pediatric care, which could narrow children’s access to care, according to a 20-year review published Dec. 10 in Pediatrics. Researchers examined an average of 3,927 hospitals annually between 2003 and 2022 using the Healthcare Cost and…

The FDA has approved Waskyra (etuvetidigene autotemcel), the first gene therapy for Wiskott-Aldrich syndrome, a rare and life-threatening immune disorder. Waskyra is indicated for pediatric patients 6 months and older, as well as adults with Wiskott-Aldrich syndrome who are eligible…

HeartBeam has received FDA clearance for its synthesized 12-lead ECG software, making it the first cable-free device of its kind for at-home arrhythmia assessment. The clearance followed a successful appeal of a previous not substantially equivalent determination, the company said…

Advertisement